About
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.
- Website
- Headquarters
- Industry
- Social
Team
View all (21)Praveen Tipirneni
President and CEO
Adrian S. Ray
Vice President and Head of Translational Sciences
Blaise Lippa
Head of Chemistry
Bruce Rogers
Chief Scientific Officer
Marc Schegerin
Chief Financial Officer and Chief Operating Officer
Peter G. Linde
Chief Medical Officer
Robert E. Farrell Jr.
Vice President of Finance/Operations and Treasurer
William DeVaul
General Counsel and Secretary
Albert Robichaud
Scientific Advisor
Amir Nashat
Director
Gustav Christensen
Director
Joseph P. Slattery
Director
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.